Skip to main content
Equibles

BARCLAYS PLC

Position in CDXS — Codexis, Inc.

CIK 312069 LONDON, X0
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$350,918
+$98,117 QoQ
Shares Held
155,274
+0.1% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. CDXS ranks #190 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in CDXS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $350,918 155,274
2026-03-31 $252,801 155,093
2025-12-31 $399,107 244,851
2025-09-30 $547,759 224,492
2025-06-30 $618,879 253,639
2025-03-31 $532,980 198,134
2024-12-31 $1,131,329 237,176
2024-09-30 $639,494 207,628
2024-06-30 $425,856 137,373
2024-03-31 $574,370 164,576
2023-12-31 $657,052 215,427
2023-09-30 $293,053 155,055
2023-06-30 $119,744 42,766
2023-03-31 $250,291 60,457
2022-12-31 $172,382 36,992
2022-09-30 $172,037 28,389
2022-06-30 $217,871 20,829
2022-03-31 $602,640 29,226
2021-12-31 $2,398,221 76,694
2021-09-30 $1,297,488 55,782
2021-06-30 $498,995 22,021
2021-03-31 $1,480,547 64,681
2020-12-31 $424,854 19,462
2020-09-30 $288,804 24,600
2020-06-30 $336,208 29,492
2020-03-31 $196,036 17,566